HOCOR Cardiovascular Technologies
Our life-saving temporary heart valve catheter is 10 pigs away from FDA approval for human use.
HOCOR has developed a temporary heart valve catheter that can save lives in an emergency. Our invention has been awarded 7 patents (6US, 1EU), and the technology has been further validated in 8 medical journal publications. The FDA has written us a letter stating their approval for human use after the last round study using 10 pigs and the clinical prototype. The cost of this final step toward human use in the US is estimated to be $500,000.